SPHERE Per-AF Post-Approval Study

计划入组 200 人 · 首次发布于 2025 年 3 月 5 日

Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sphere-9 Catheter and Affera Ablation System (Conquer-AF)

计划入组 400 人 · 首次发布于 2025 年 12 月 23 日

Clinical Evaluation of Biomedics Monthly Sphere and Avaira Vitality Sphere

计划入组 44 人 · 首次发布于 2024 年 5 月 6 日

PER-1080

PER-312

PER-002

Ennar Pharmaceuticals AF

Micro-Sphere SA

Switzerland

Sphere Healthcare Pty Ltd.

Australia

NCH Rooney Heart Institute Announces Successful Clinical Trial of Medtronic's SPHERE Per-AF Technology for Atrial Fibrillation

FDA Approves Medtronic's Affera System for Atrial Fibrillation Ablation

FDA Approves Medtronic's Affera System, a Dual-Energy Ablation Technology for Atrial Fibrillation